Democrats look likely to take a first, but relatively limited, action on drug pricing in the upcoming budget reconciliation bill that the Biden White House aims to use to get its $1.9 trillion coronavirus relief package through the US Congress.
The important question for pharmaceutical companies may be whether this action is a sign Democrats will only take small steps...







